superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2022-06-30
- Valid until
- 2022-09-30
- Published
- 2022-08-02
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 10,410,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Abbott Laboratories quarterly revenue: 11,257,000,000 United States dollar", as of 2022-06-30 (until 2022-09-30). Claim clm_3FFAC71D1875, https://asof.is/claim/clm_3FFAC71D1875, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828022020209/0001628280-22-020209-index.htm.
APA
AsOf. (2022). Abbott Laboratories quarterly revenue: 11,257,000,000 United States dollar (as of 2022-06-30 (until 2022-09-30)) [Record clm_3FFAC71D1875]. Retrieved November 9, 2026, from https://asof.is/claim/clm_3FFAC71D1875 (source: https://www.sec.gov/Archives/edgar/data/1800/000162828022020209/0001628280-22-020209-index.htm)
BibTeX
@misc{asof_clm_3FFAC71D1875,
author = {AsOf},
title = {Abbott Laboratories quarterly revenue: 11,257,000,000 United States dollar},
year = {2022},
howpublished = {\url{https://asof.is/claim/clm_3FFAC71D1875}},
note = {Claim clm\_3FFAC71D1875, as of 2022-06-30 (until 2022-09-30); source: https://www.sec.gov/Archives/edgar/data/1800/000162828022020209/0001628280-22-020209-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_3FFAC71D1875.md/v1/claims/clm_3FFAC71D1875submit a correction